ETS2 and cancer: Given that approximately half of all the mtp53 binding sites in the genome harbor an ETS motif, our data indicate that by protecting its preferred binding partner, ETS2, mtp53 enhances its ability to transcriptionally regulate a multitude of genes involved in cancer progression.